Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Atazavanir/Ritonavir-based HAART in Children

This study has been completed.
amfAR, The Foundation for AIDS Research
National Health Security Office, Thailand
The Thai Government Pharmaceutical Organization (GPO)
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration Identifier:
First received: July 17, 2012
Last updated: August 25, 2014
Last verified: August 2014